Navigation Links
Understanding Restless Legs Syndrome

Restless legs syndrome is an irritating feeling of uneasiness, tiredness and itching deep in the muscles of the legs. The symptoms can be painful // and often worsen at night.

A new study aims to better understand the common condition called restless legs syndrome. Studies on restless legs syndrome are rare. However, researchers in Germany recently conducted a population-based study to look at the prevalence and factors related to restless legs syndrome.

The study was conducted by doing interviews and physical examinations with 4,310 participants. The participants were between 20 and 79 years old and were randomly selected to participate. Doctors assessed whether each participant had restless legs syndrome and how it affected his or her quality of life.

Researchers report the overall prevalence of restless legs syndrome was 10.6 percent. They found the disease prevalence increased with age and women were twice as likely to have it as men. Also, researchers report the risk of restless legs syndrome increased for women who had children. The more children the woman gave birth to, the more likely she was to have restless legs syndrome. Researchers also reported people with restless legs syndrome had significantly lower quality of life scores than those without the syndrome. This means the disease affects the everyday activities of the people who suffer from it.

Researchers conclude restless legs syndrome is a common disease in the general population. They feel since restless legs syndrome can be treated effectively, the medical community and the public need to be better educated about this disease.
'"/>




Page: 1

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Lung Cancer Metastasis
3. Understanding The Link Between Hormone Replacement and Respiratory Disease
4. Understanding The Risks Of Hormone Therapy
5. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
6. A Better Understanding Of The Brain Network
7. Understanding The Predictor’s Of Alzheimer’s Diseae
8. Understanding The Harmful Effects Of Radiation Exposure
9. Understanding The Origin Of Tumors
10. Understanding Insulin Resistance
11. Understanding The Link Between Phobias And Fatal Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: